Learn more →
Back to Expert Scholars
clinical / clinicalcombination chemotherapy leukemia pioneer

Emil J. Freireich

埃米尔·弗雷瑞克

MD

🏢University of Texas MD Anderson Cancer Center (Legacy, 1927-2021)(德克萨斯大学MD安德森癌症中心(历史,1927-2021))🌐USA

Professor Emeritus (Legacy)名誉教授(历史)

72
h-index
2
Key Papers
3
Awards
2
Key Contributions

👥Biography 个人简介

Emil Freireich was a revolutionary oncologist who pioneered combination chemotherapy protocols that first achieved remissions and eventual cures in childhood acute lymphoblastic leukemia. Working with Emil Frei III and James Holland at the National Cancer Institute in the late 1950s and 1960s, Freireich developed the VAMP (vincristine, amethopterin, 6-mercaptopurine, prednisone) combination regimen that produced complete remissions in ALL. His persistence against strong institutional skepticism, his advocacy for aggressive treatment of pediatric cancer, and his invention of platelet transfusions to manage treatment-associated bleeding collectively transformed childhood leukemia from universally fatal to potentially curable. His insistence that combination chemotherapy could cure cancer was prescient and foundational.

Share:

🧪Research Fields 研究领域

combination chemotherapy leukemia白血病联合化疗
platelet transfusions血小板输血
pediatric leukemia cures儿科白血病治愈
VAMP regimenVAMP方案
clinical trial innovation临床试验创新

🎓Key Contributions 主要贡献

VAMP Combination Chemotherapy in ALL

Developed and championed VAMP and related combination chemotherapy regimens for childhood ALL at NCI, achieving the first durable complete remissions and establishing the principle that combination chemotherapy could cure human cancer.

Platelet Transfusion Innovation

Invented the concept and technique of platelet transfusions to manage chemotherapy-induced thrombocytopenia and prevent fatal hemorrhage, enabling dose-intensive chemotherapy administration that would otherwise be impossible.

Representative Works 代表性著作

[1]

The Effect of 6-Mercaptopurine on the Duration of Steroid-Induced Remissions in Acute Leukemia

Blood (1963)

Combination chemotherapy extending remissions in childhood leukemia.

[2]

Platelet Transfusions as Therapy for Thrombocytopenia

Cancer Research (1963)

Introduction of platelet transfusions enabling dose-intensive chemotherapy.

🏆Awards & Recognition 奖项与荣誉

🏆AACR Award for Lifetime Achievement in Cancer Research
🏆National Medal of Science
🏆ASCO Distinguished Achievement Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 埃米尔·弗雷瑞克 的研究动态

Follow Emil J. Freireich's research updates

留下邮箱,当我们发布与 Emil J. Freireich(University of Texas MD Anderson Cancer Center (Legacy, 1927-2021))相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment